Skip to main content

Series B Therapeutics Companies

Explore 82 therapeutics startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
82
Total Funding
$1.7B
Avg Funding
$66.1M
Cities
22

Export 82 Series B Therapeutics Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Leiden, The Netherlands
$146.7M
raised

Azafaros aims at developing new therapeutic agents for the treatment of rare metabolic disorders.

May 2025
Series B

Founder Contacts

19,000+ verified contacts

Newark, United States
$29.4M
raised

Ace Vision Group develop laser-based therapeutic technologies to heal age-related eye dysfunction and restore the eye's natural performance.

Apr 2025
Series B

Founder Contacts

19,000+ verified contacts

Basel, Switzerland
$70.0M
raised

Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.

Apr 2025
Series B

Founder Contacts

19,000+ verified contacts

Boston, United States
$65.0M
raised

Ampersand Biomedicines is a multi-product platform that develops programmable medicines that target disease sites precisely.

Mar 2025
Series B

Founder Contacts

19,000+ verified contacts

San Diego, United States
$18.0M
raised

Gallant is advancing investigational stem cell therapies to help give pets more good years, making regenerative care more accessible.

Mar 2025
Series B

Founder Contacts

19,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 82 funded startups

19,000+ verified emails
Unlimited exports
No credit card required
Paris, France
$28.2M
raised

EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.

Feb 2025
Series B

Founder Contacts

19,000+ verified contacts

New Haven, United States
$75.0M
raised

Normunity develops precision immuno-oncology medicines that enable normal immunity against cancer.

Jan 2025
Series B

Founder Contacts

19,000+ verified contacts

Redwood City, United States
$50.0M
raised

Ashvattha Therapeutics is a clinical-stage biopharmaceutical company that develops precision nanomedicines for ophthalmology diseases.

Jan 2025
Series B

Founder Contacts

19,000+ verified contacts

Durham, United States
$175.0M
raised

Tune Therapeutics is an epigenetic programming platform for the treatment of disease.

Jan 2025
Series B

Founder Contacts

19,000+ verified contacts

Redwood City, United States
$161.0M
raised

Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.

Dec 2024
Series B

Founder Contacts

19,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 82 funded startups

19,000+ verified emails
Unlimited exports
No credit card required
Laval-ouest, Canada
$40.6M
raised

KisoJi Biotechnology is a biotechnology company focused on healthcare and life sciences for research and development industries.

Dec 2024
Series B

Founder Contacts

19,000+ verified contacts

London, United Kingdom
$104.5M
raised

Purespring Therapeutics is a gene therapy company that provides treatments for different kidney diseases.

Oct 2024
Series B

Founder Contacts

19,000+ verified contacts

Watertown, United States
$115.0M
raised

Triveni Bio is a a biotech company that develops functional antibodies targeting immunological and inflammatory disorders.

Oct 2024
Series B

Founder Contacts

19,000+ verified contacts

Palo Alto, United States
$67.0M
raised

OrsoBio is a clinical-stage biopharmaceutical company that develops therapies to treat severe metabolic disorders.

Sep 2024
Series B

Founder Contacts

19,000+ verified contacts

Los Gatos, United States
$30.0M
raised

Venova Medical develops vascular access systems for patients requiring renal replacement therapy.

Sep 2024
Series B

Founder Contacts

19,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 82 funded startups

19,000+ verified emails
Unlimited exports
No credit card required
Melbourne, Australia
$9.5M
raised

Kinoxis Therapeutics is a biotechnology company that develops a range of novel therapeutic compounds.

Aug 2024
Series B

Founder Contacts

19,000+ verified contacts

New Haven, United States
$126.0M
raised

Halda Therapeutics is a research-stage drug discovery company.

Aug 2024
Series B

Founder Contacts

19,000+ verified contacts

San Diego, United States
$21.8M
raised

Kate Therapeutics is a biotechnology company focused on developing next-generation gene therapies for muscle and heart diseases.

Aug 2024
Series B

Founder Contacts

19,000+ verified contacts

Ohio, United States
$12.3M
raised

Neuro Therapia is developing new therapies for diseases with an underlying component of neuroinflammation.

Aug 2024
Series B

Founder Contacts

19,000+ verified contacts

Los Angeles, United States
$1.0M
raised

Nammi Therapeutics is an immunotherapy company that develops nano-enabled chemo-immunotherapy for the treatment of cancer.

Aug 2024
Series B

Founder Contacts

19,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 82 funded startups

19,000+ verified emails
Unlimited exports
No credit card required
Alameda, United States
$125.0M
raised

Santa Ana Bio is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.

Jun 2024
Series B

Founder Contacts

19,000+ verified contacts

Emeryville, United States
$55.0M
raised

Prolific Machines unlocks production of next-generation therapeutics with a light-controlled gene expression system and closed-loop control.

Jun 2024
Series B

Founder Contacts

19,000+ verified contacts

Long Island City, United States
$25.0M
raised

Envisagenics reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.

Jun 2024
Series B

Founder Contacts

19,000+ verified contacts

Philadelphia, United States
$51.4M
raised

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

Jun 2024
Series B

Founder Contacts

19,000+ verified contacts

Abingdon, United Kingdom
$50.0M
raised

We are advancing novel antigen modulation technology that controls T cells to guide the immune system.

May 2024
Series B

Founder Contacts

19,000+ verified contacts

Showing 26 to 50 of 82 companies

Ready to Connect with Series B Therapeutics Startups?

Get verified founder emails, funding details, and company data for 82 series b therapeutics companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked